Integrating transcriptomics, metabolomics, and network pharmacology to investigate multi-target effects of sporoderm-broken spores of Ganoderma lucidum on improving HFD-induced diabetic nephropathy rats

Diabetes mellitus (DM) is a major metabolic disease endangering global health, with diabetic nephropathy (DN) as a primary complication lacking curative therapy. Sporoderm-broken spores of Ganoderma lucidum (GLP), an herbal medicine, has been used for the treatment of metabolic disorders. In this st...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Lidan Hu, Lili Yu, Zhongkai Cao, Yue Wang, Caifeng Zhu, Yayu Li, Jiazhen Yin, Zhichao Ma, Xuelin He, Ying Zhang, Wunan Huang, Yuelin Guan, Yue Chen, Xue Li, Xiangjun Chen
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2024-12-01
Sarja:	Journal of Pharmaceutical Analysis
Aiheet:	Diabetic nephropathy Metabolome Network pharmacology Sporoderm-broken spores of Ganoderma lucidum Transcriptome
Linkit:	http://www.sciencedirect.com/science/article/pii/S2095177924002028
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!